2011ǯ12·î16Æü

´µ¼Ô¤ÎÉþÌô¹ÔÆ°¡§¤ä¤Ï¤ê¥¢¥á¥ê¥«¿Í¤Ï¤¤¤¤²Ã¸º

adherence curves

Î㤨¤Ð¡¢¤¢¤ë´µ¼ÔÁü¤ò¹Í¤¨¤Æ²¼¤µ¤¤¡£
42ºÐ¤ÎÃËÀ­¡¢´ûº§¤Ç»Ò¶¡°ì¿Í¡£¼þ3-4²ó¤Î¥Ú¡¼¥¹¤Ç¥Õ¥£¥È¥Í¥¹¥¯¥é¥Ö¤ËÄ̤¤¥¦¥¨¡¼¥È¥È¥ì¡¼¥Ë¥ó¥°¤ò¤¹¤ë¸µ¥¹¥Ý¡¼¥Ä¥Þ¥ó¡£·ò¹¯¤½¤¦¤Ç¤¢¤ê¡¢¼«³Ð¾É¾õ¤Ï²¿¤â¤Ê¤¤¡£¤¬¡¢²È²¤ÎÉÂÎò¤Ï¤«¤Ê¤êÂçÊѤǡ¢¤¢¤é¤æ¤ëCV¼À´µ¡¢ÅüǢɡ¢¹Ã¾õÁ£ÌäÂê¤Ê¤É¤¬À¹¤êÂô»³¤Ç¤¢¤ë¡£BMI¤Ï26Á°¸å¡¢¥¦¥¨¥¹¥È86cm¤Î½à¥á¥¿¥ÜͽÈ÷·³¡£¿©À¸³è¤Ï°­¤¯¤Ê¤¤¤¬¡¢Æù¤È¥Ó¡¼¥ë¤¬¹¥¤­¤Ç¡¢»þ¤Ë²æËý¤Ç¤­¤Ê¤¯¤Ê¤ë·¹¸þ¤¬¶¯¤¤¤Î¤Ç¡¢µ¤¤ò¤Ä¤±¤Ê¤¤¤È¤æ¤¯¤æ¤¯¥ê¥¹¥¯¤¬¹â¤½¤¦¤À¡£Í½ËÉÂкö¤È¤·¤Æ¥µ¥×¥ê¥á¥ó¥È¤ò°û¤ó¤Ç¤¤¤ë¡£¤³¤Î¿Í¤ËÌô¤¬½èÊý¤µ¤ì¤¿¤é¡¢¤­¤Á¤ó¤ÈÉþÌô¤Ç¤­¤ë¤Î¤À¤í¤¦¤«¡£Let¡Çs check!

 

¾å¤Î¿Þ¤Ï¡¢²£¼´¤¬¥«¥ì¥ó¥À¡¼¡¢½Ä¼´¤¬»þ´Ö¤Ç¡¢¤³¤Î´µ¼Ô¤¬Íƴ狼¤éÌô¤ò½Ð¤·¤¿¥Ý¥¤¥ó¥È¤¬ÀĤ¤ÅÀ¤Ç¼¨¤µ¤ì¤Æ¤¤¤ë¤â¤Î¤Ç¡¢°ì¥ö·î´Ö¤ÎÉþÌô¾õ¶·¤¬¸«»ö¤Ëɽ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£½èÊý¤ò¤â¤é¤Ã¤¿ÅöÆü¡Ê­¡¡Ë¤ÎÌë¤Ë²È¤Ëµ¢¤Ã¤Æ½é¤á¤ÆÌô¤ò°û¤ó¤Ç¤¤¤Þ¤¹¤¬¡¢¤É¤¦¤â¤³¤Î¤È¤­2²óÍÆ´ï¤ò³«¤±¤¿¤è¤¦¤Ç¤¹¡£ÍâÆüÄ«Á᤯²È¤ò½Ð¤ë¤Î¤Çͽ¤áÌô¤ò½Ð¤·¤Æ¤ª¤¤¤¿¤Î¤«¤â¤·¤ì¤Þ¤»¤ó¡£¤Ç¤â¤½¤Î¸å¡¢Ìô¤ò³ó¤ËÆþ¤ì¤ë¤³¤È¤ò˺¤ì¤¿¤è¤¦¤Ç¡¢5Æü´Ö¤Î¥Ö¥é¥ó¥¯¤¬À¸¤¸¤Þ¤·¤¿¡Ê­¢¡Ë¡£¤½¤Î¸å¤Ï¤·¤Ð¤é¤¯Á°Ä«¤·¤Ã¤«¤ê°û¤ó¤Ç¤¤¤Þ¤·¤¿¤¬¡¢¤ä¤Ï¤ê¤Á¤ç¤³¤Á¤ç¤³Ëº¤ì¤¿¤ê¤·¤Æ¡¢¤½¤ì¤«¤é¤Þ¤¿Ê̤νÐÄ¥¤«¤Ê¡Ê­£¡Ë¡£¤½¤Î¸å¤â¥Ñ¥¿¡¼¥ó¤Ï¥Þ¥Á¥Þ¥Á¤Ç¡¢·ë¶É¤³¤Î°ì¥ö·î¤Î¥³¥ó¥×¥é¥¤¥¢¥ó¥¹Î¨¤Ï54%¤Ç¤·¤¿¡£

 

¤·¤«¤·Äü¤á¤ë¤Î¤Ï¤Þ¤ÀÁᤤ¡ª²¿¤«¥ê¥Þ¥¤¥ó¥À¡¼¤¬½Ð¤µ¤ì¤¿¤È¤·¤¿¤é¡¢´µ¼Ô¤Î¹ÔÆ°¤ÏÊѤï¤ë¤Î¤Ç¤·¤ç¤¦¤«¡©¡¡¤³¤Î¾ì¹ç¡¢¤¢¤ë¥Ä¡¼¥ë¤Î»È¤¤Êý¤Ë¤Ä¤¤¤Æ²þ¤á¤ÆÀâÌÀ¤ò¼õ¤±¤¿¸å¡¢¤³¤Î´µ¼Ô¤Î¹ÔÆ°¤Ï²¼¤Î¿Þ¤Î¤è¤¦¤ËÊѤï¤ê¤Þ¤·¤¿¡£

 

²£¼´²¼Éô¤Î¹õ¤¯Åɤé¤ì¤Æ¤¤¤ëÉôʬ¤¬½µËö¤Îɽ¼¨¤Ê¤Î¤Ç¡¢¤É¤¦¤â¿åÍËÆü¤È¶âÍËÆü¤Ë¤Þ¤À²¿¤«ÌäÂ꤬¤¢¤ê¤½¤¦¤Ç¤¹¤¬¡¢Á´ÂÎŪ¤Ë°ìÄê¤Î»þ´ÖÂÓ¤ËËèÆü¤Î¤è¤¦¤ËÉþÌô¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤ê¡¢¥³¥ó¥×¥é¥¤¥¢¥ó¥¹Î¨¤Ï84%¤Ë¾å¾º¤·¤Þ¤·¤¿¡£Good!

 

¤â¤¦´û¤ËÁÛÁü¤·¤Æ¤¤¤ëÊý¤â¤¤¤ë¤«¤È»×¤¤¤Þ¤¹¤¬¡¢¤³¤Î´µ¼Ô¤Ï»ä¤Ç¤¹¡£¡ÖÆüËܿͤè¤ê¤âÆüËÜŪ¤À¡×¤È¤¿¤Þ¤Ë¸À¤ï¤ì¤ë¤³¤È¤â¤¢¤ê¤Þ¤¹¤¬¡¢»ä¤Î¤è¤¦¤Ê¤¤¤¤²Ã¸º¤Ê¥¢¥á¥ê¥«¿Í¤Ç¤â¡¢¤·¤Ã¤«¤ê¤È»ØƳ¤ò¼õ¤±¤ì¤Ð¤½¤ì¤Ê¤ê¤Ë¤Ç¤­¤ë¤ó¤Ç¤¹¤è¡ª

 

¾åµ­¤Î¤è¤¦¤Ê¥Ä¡¼¥ë¤ÏMedication Event Monitoring¤È¸Æ¤Ð¤ì¤Æ¤¤¤Þ¤¹¡£¿ô¤«·îÁ°¤Ë¥è¡¼¥í¥Ã¥Ñ¤Ë¹Ô¤¯µ¡²ñ¤¬¤¢¤ê¡¢¤³¤ÎʬÌî¤Ç³èÌö¤·¤Æ¤¤¤ë¤¢¤ë²ñ¼Ò¤òˬÌ䤷¤Þ¤·¤¿¡£¤½¤³¤Çºî¤é¤ì¤Æ¤¤¤ë¥·¥¹¥Æ¥à¤ò»ý¤Ã¤Æµ¢¤ê¡¢º£¾åµ­¤Î¤è¤¦¤ËÊÙ¶¯¤·¤Æ¤¤¤ëÃʳ¬¤Ç¤¹¡£¼ïÌÀ¤«¤·¤ò¤¹¤ë¤È¡¢Ìô¤Î¥Ü¥È¥ë¥­¥ã¥Ã¥×¤Î¤Ê¤«¤Ë¥»¥ó¥µ¡¼¤¬¤¢¤ê¡¢¤½¤Î¥Ó¥ó¤ò³«¤¯Å٤˥»¥ó¥µ¡¼¤¬µ¯Æ°¤·¤Æµ­Ï¿¤ò¥È¥é¥Ã¥­¥ó¥°¤·¤Æ¤¤¤­¤Þ¤¹¡£Äê´üŪ¤Ë¤½¤Î¥Ç¥¸¥¿¥ë¥­¥ã¥Ã¥×¤ò¥³¥ó¥Ô¥å¡¼¥¿¤Ë¤Ä¤Ê¤²¤ì¤Ð¡¢¥Ç¡¼¥¿ÄÌ¿®¤Ë¤è¤êWeb¾å¤Ç¾åµ­¤Î¤è¤¦¤Ê¥¢¥¦¥È¥×¥Ã¥È¤¬¸«¤¨¤ë»ÅÁȤߤޤǴ°À®¤µ¤»¤Æ¤¤¤Þ¤¹¡£

 

³¤³°¤Ç¤Î¼ç¤Ê±þÍѾìÌ̤ÏÎ×¾²»î¸³¤À¤½¤¦¤Ç¤¹¡£¸úǽ¤Ë±Æ¶Á¤òÍ¿¤¨¤ë¤è¤¦¤Ê¤³¤È¤¬¤¢¤ì¤Ð¡¢¼Á¤Î°­¤¤¾ÉÎã¥Ñ¥¿¡¼¥ó¤È¤½¤¦¤Ç¤Ê¤¤¥Ñ¥¿¡¼¥ó¤ò¤·¤Ã¤«¤ê¤ÈÇÄ°®¤·¤ÆʬÀϤ¹¤ë¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£¤³¤³¿ôǯ´Ö¤Ï¡¢°åÎŲðÆþ¥×¥í¥°¥é¥à¤Ç¤âÍøÍѤµ¤ì¤ë¤³¤È¤¬Â¿¤¯¤Ê¤Ã¤Æ¤­¤Æ¤¤¤Þ¤¹¡£¥Þ¡¼¥±¥¿¡¼¤Î»ëÅÀ¤ÇÌÌÇò¤¤¤È»×¤¦¤Î¤Ï¡¢¤¿¤È¤¨¤Ð¾å»Ô¸å¤ÎÌôºÞ¤Ç¤¢¤ì¤Ð°å¼Ô¤äÌôºÞ»Õ¤Ë¤³¤Î¤è¤¦¤Ê¥Ä¡¼¥ë¤òÍÑ°Õ¤·¤Æ´µ¼Ô¤µ¤ó¤ËÅϤ·¤Æ¤â¤é¤¤¡¢Äê´üŪ¤Ë·ë²Ì¤ò°ì½ï¤Ë¥Ç¥£¥¹¥«¥Ã¥·¥ç¥ó¤¹¤ë¤è¤¦¤Ê¥×¥í¥°¥é¥à¤òºî¤ê¤Þ¤¹¡£²Ä»ë²½¤µ¤ì¤¿ºàÎÁ¤¬¤¢¤ì¤Ð¼£ÎŤäÉþÌô»ØƳ¤¬¤ä¤ê¤ä¤¹¤¯¤Ê¤ê¡¢´µ¼Ô¤µ¤ó¤ÎÁêÃ̤ÎÉÑÅÙ¤â¾å¤¬¤ë¤Ç¤·¤ç¤¦¡£À½Ìô´ë¶È¤âWIN¡¢´µ¼Ô¤µ¤ó¤âWIN¡¢°åÎŵ¡´Ø¤âWIN¡£¤·¤Ã¤«¤ê¤È¤·¤¿¥±¥¢¤¬¤Ç¤­¡¢¥¢¥¦¥È¥«¥à¤¬¤è¤¯¤Ê¤ë¤Ï¤º¤À¤«¤é¡¢¹ñ¤À¤Ã¤ÆWIN¤Ë¤Ê¤ë¤Ï¤º¡£WIN¡ÝWIN¤ÎÇܤǤ¹¤è¡ªÌÌÇò¤¤ÏäÀ¤È³Î¿®¤·¤Æ¤¤¤Þ¤¹¡£

 

¤³¤Î¥·¥¹¥Æ¥à¤Ï¤Þ¤À´°¤Ú¤­¤Ç¤Ï¤Ê¤¤¤Ç¤¹¤¬¡¢ÆÃÉ®¤¹¤Ù¤­¤Ï´µ¼Ô¤Ë¥Õ¥©¡¼¥«¥¹¤·¤Æ¤¤¤ë¤³¤È¤È¡¢¡Ö°ì²óÄϤó¤À¸ÜµÒ¤ò¤·¤Ã¤«¤ê¤È¥Õ¥©¥í¡¼¤¹¤ë¡×¤È¤¤¤¦Â¾¶È³¦¤Ç¤Î¾ï¼±¤ò¡¢À½Ìô¥Þ¡¼¥±¥¿¡¼¤â»ý¤Æ¤ë¤è¤¦¤Ê»þÂå¤Ë¤Ê¤Ã¤¿¤³¤È¡£¤Þ¤À¤Þ¤À¼êõ¤ê¾õÂ֤ǤϤ¢¤ê¤Þ¤¹¤¬¡¢Åö¼Ò¤Ç¤Ï¤³¤Î¤è¤¦¿·¤·¤¤¼è¤êÁȤߤ˥ȥ饤¤¹¤ë´ë¶È¤ò°ì½ï¤Ë±þ±ç¤·¤¿¤¤¤È»×¤Ã¤Æ¤¤¤Þ¤¹¡£¤´°Õ¸«¤ò¤ªÂÔ¤Á¤·¤Æ¤¤¤Þ¤¹¡ª


¾åµ­¤Îµ­»ö¤Î¥ª¥ê¥¸¥Ê¥ë¤Ï¥ß¥¯¥¹¥ª¥ó¥é¥¤¥ó¤Ë£²£°£±£°Ç¯£³·î£±£·Æü¤ËÅê¹Æ¤·¤Þ¤·¤¿¡£

http://www.mixonline.jp/Article/tabid/55/artid/38743/Default.aspx



jeffjapan at 12:30¨¢¥³¥á¥ó¥È(0)¨¢¥È¥é¥Ã¥¯¥Ð¥Ã¥¯(0)¨¢Marketing | Pharma/Healthcare 

¥È¥é¥Ã¥¯¥Ð¥Ã¥¯URL

¥³¥á¥ó¥È¤¹¤ë

̾Á°:
URL:
  ¾ðÊó¤òµ­²±¡§ ɾ²Á¡§  ´é   À±
 
 
 
µ­»ö¸¡º÷